Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC

被引：45
|
作者：
Risiglione, Pierpaolo [1 ]
Zinghirino, Federica [1 ]
Di Rosa, Maria Carmela [1 ]
Magri, Andrea [2 ,3 ]
Messina, Angela [2 ,3 ]
机构：
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[2] Univ Catania, Dept Biol Geol & Environm Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[3] WeMitoBiotech SRL, C So Italia 172, I-95125 Catania, Italy
来源：
BIOMOLECULES | 2021年 / 11卷 / 05期
关键词：
Alpha-Synuclein; mitochondria; VDAC; Parkinson's disease; mitochondrial dysfunction; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY PROTEINS; COMPLEX-I DEFICIENCY; OXIDATIVE STRESS; HEXOKINASE-I; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; SUPEROXIDE-PRODUCTION; OLIGOMERS INTERACT;
D O I：
10.3390/biom11050718
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alpha-Synuclein (alpha Syn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) proteins are the main gates for ADP/ATP and various substrates towards the organelle. Furthermore, they act as a mitochondrial hub for many cytosolic proteins, including alpha Syn. This review analyzes the main aspects of alpha Syn-mitochondria interaction, focusing on the role of VDAC and its emerging involvement in the pathological processes.
引用
收藏
页数：19
相关论文
共 50 条
  • [21] Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
    Richard M. Meade
    David P. Fairlie
    Jody M. Mason
    Molecular Neurodegeneration, 14
  • [22] Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease
    Banabihari Giri
    Marissa Seamon
    Aditi Banerjee
    Sneha Chauhan
    Sharad Purohit
    John Morgan
    Babak Baban
    Chandramohan Wakade
    Metabolic Brain Disease, 2022, 37 : 1687 - 1696
  • [23] Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease
    Giri, Banabihari
    Seamon, Marissa
    Banerjee, Aditi
    Chauhan, Sneha
    Purohit, Sharad
    Morgan, John
    Baban, Babak
    Wakade, Chandramohan
    METABOLIC BRAIN DISEASE, 2022, 37 (06) : 1687 - 1696
  • [24] Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease
    Shen, Lydia
    Dettmer, Ulf
    BIOMOLECULES, 2024, 14 (12)
  • [25] The Role of Astrocytes and Alpha-Synuclein in Parkinson's Disease: A Review
    Brash-Arias, David
    Garcia, Luis I.
    Perez-Estudillo, Cesar Antonio
    Rojas-Duran, Fausto
    Aranda-Abreu, Gonzalo Emiliano
    Herrera-Covarrubias, Deissy
    Chi-Castaneda, Donaji
    NEUROSCI, 2024, 5 (01): : 71 - 86
  • [26] Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease
    Fitzgerald, Emily
    Murphy, Sarah
    Martinson, Holly A.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [27] Role of alpha-synuclein in the neurodegeneration of Parkinson disease
    Schlossmacher, M. G.
    MOVEMENT DISORDERS, 2006, 21 : S450 - S450
  • [28] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428
  • [29] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [30] Peripheral Alpha-Synuclein and Parkinson's Disease
    Olanow, C. Warren
    Wakeman, Dustin R.
    Kordower, Jeffrey H.
    MOVEMENT DISORDERS, 2014, 29 (08) : 963 - 966
12345